esketamine Side Effects
Also known as: Spravato
Analysis of 15,846 adverse event reports submitted to the FDA from 2015 to 2025.
Total Reports
15,846
Death-Related
641
4.0% of reports
Hospitalizations
2,714
17.1% of reports
Top Indication
Depression
Most Reported Adverse Reactions
Who Reports Side Effects
Gender Distribution
Age Distribution
Reporting Trend by Year
Reactions in Death Reports
Top reactions reported in 641 reports where death was an outcome. These are voluntarily reported and do not establish causation.
| Reaction | Reports |
|---|---|
| DEATH | 291 |
| COMPLETED SUICIDE | 229 |
| DRUG INEFFECTIVE | 19 |
| ROAD TRAFFIC ACCIDENT | 15 |
| PRODUCT DOSE OMISSION ISSUE | 14 |
| OVERDOSE | 13 |
| SUICIDAL IDEATION | 13 |
| DEPRESSION | 12 |
| SEDATION | 11 |
| DISSOCIATION | 10 |
| MYOCARDIAL INFARCTION | 10 |
| SUICIDE ATTEMPT | 10 |
| ANXIETY | 9 |
| COVID-19 | 8 |
| CARDIAC ARREST | 7 |
| HOSPITALISATION | 7 |
| FALL | 6 |
| INTENTIONAL OVERDOSE | 5 |
| NEOPLASM MALIGNANT | 5 |
| PULMONARY EMBOLISM | 5 |
Reactions in Hospitalization Reports
Top reactions in 2,714 reports where hospitalization was an outcome.
| Reaction | Reports |
|---|---|
| HOSPITALISATION | 696 |
| SUICIDAL IDEATION | 329 |
| DISSOCIATION | 313 |
| SEDATION | 207 |
| DEPRESSION | 198 |
| SUICIDE ATTEMPT | 172 |
| HYPERTENSION | 117 |
| DRUG INEFFECTIVE | 112 |
| ANXIETY | 89 |
| PRODUCT DOSE OMISSION ISSUE | 77 |
| NAUSEA | 71 |
| BLOOD PRESSURE INCREASED | 67 |
| VOMITING | 66 |
| OFF LABEL USE | 64 |
| DIZZINESS | 63 |
| SURGERY | 63 |
| FALL | 53 |
| SEIZURE | 52 |
| PANIC ATTACK | 49 |
| MENTAL DISORDER | 44 |
Nearby — Related Medications
What the FAERS Data Reveals About esketamine Side Effects
The FDA Adverse Event Reporting System (FAERS) contains 15,846 voluntary reports linked to esketamine and its brand equivalents (Spravato), spanning 2015 through 2025. Of those, 641 (4.0%) listed death as an outcome and 2,714 (17.1%) involved hospitalization. The most common indication reported alongside adverse events was Depression.
Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 66% were female and 34% male; age distribution skews toward 18-44, with 4,243 reports in that bracket. The single most reported reaction is dissociation with 3,351 submissions, followed by sedation and suicidal ideation.
FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice — speak with a licensed clinician about any side-effect concerns.
Read our methodology — how this data is sourced, computed, and verified.